Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm.

NPJ systems biology and applications·2022
Same author

COVID-19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.

Molecular systems biology·2021
Same author

Author Correction: The Aphelenchus avenae genome highlights evolutionary adaptation to desiccation.

Communications biology·2021
Same author

The Aphelenchus avenae genome highlights evolutionary adaptation to desiccation.

Communications biology·2021
Same author

COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.

Molecular systems biology·2021
Same author

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the <i>mdx</i> Mouse Model and Patients.

Frontiers in physiology·2021
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational Risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
Same journal

Balancing optimism versus potential risks of AI-driven drug discovery.

Expert opinion on drug discovery·2026
Same journal

Trustworthy and explainable AI for drug discovery.

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Contextual data integration in drug discovery.

Anton Yuryev1

  • 1Elsevier, Ariadne Genomics, Inc., Rockville, MD 20878, USA. ayuryev@ariadnegenomics.com

Expert Opinion on Drug Discovery
|June 5, 2012
PubMed
Summary
This summary is machine-generated.

Using context-specific pathway analysis improves high-throughput data interpretation. Incorporating tissue-specific interactions and pathways reduces inaccuracies in molecular profiling data analysis.

Related Experiment Videos

Last Updated: May 21, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Genomics

Background:

  • High-throughput profiling data interpretation relies heavily on pathway analysis databases.
  • Current methods often use general human tissue data due to limited context-specific knowledge.
  • Tissue-specific proteome and interactome analyses reveal significant variations, highlighting the impact of biological context on data accuracy.

Purpose of the Study:

  • To review biological context classes for molecular interaction and pathway detection.
  • To evaluate methods for predicting biological interactions for pathway analysis.
  • To estimate accuracy gains in pathway analysis using context-specific versus context-independent data.

Main Methods:

  • Literature review of biological context in molecular interaction detection.
  • Review of interaction prediction methods for pathway analysis applicability.
  • Estimation of accuracy improvements using context-specific interaction data based on tissue composition studies.

Main Results:

  • Significant differences in tissue proteomes and interactomes exist globally.
  • Context-independent pathway analysis introduces inaccuracies and noise.
  • Using context-specific interactions can substantially improve pathway analysis accuracy.

Conclusions:

  • Lack of tissue-specific transcriptional regulation knowledge is a key source of pathway analysis inaccuracy.
  • Utilizing context-specific interactions and pathways is crucial for improving analysis accuracy.
  • The study advocates for context-aware approaches in interpreting molecular profiling data.